NASDAQ$RAPP
Rapport Therapeutics Inc · Q2 2026 earnings
Q2 2026 earnings · · Before market open
Reports in 3 weeks
Rapport Therapeutics Inc hasn't published Q2 2026 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.
Most recent report Q1 2026
- Revenue
- $20M
- EPS
- -$0.42
Revenue & EPS history
Rapport Therapeutics Inc · Revenue · Quarterly
$20M
Q1 2026
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 2 quarterly earnings reports
+2.2%
Avg return
Earnings day
-4.2%
Avg return
5 days after
+4.7%
Avg return
30 days after
50%
1 / 2 earnings
Positive
+7.4%
Q1 2026
Best reaction
-3.0%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +7.4% | +0.4% | -2.7% | |
| Q4 2025 | -3.0% | -8.8% | +12.0% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro